Read here📄 https://bit.ly/4pw1rVL
Read here📄 https://bit.ly/4pw1rVL
Explore this investigational approach live at 12:45 pm ET or on demand afterward through June 11, 2027.
Register: www.medlive.com/aaci/show/26...
#LungCancer #NSCLC
Explore this investigational approach live at 12:45 pm ET or on demand afterward through June 11, 2027.
Register: www.medlive.com/aaci/show/26...
#LungCancer #NSCLC
We've seen PD-1 agonists - rosnilimab's phase 2b
What about other immune checkpoint agonists, though?
LAG-3 we know from ICI therapy (relatlimab)
Prepare to see LAG-3 agonist drug development soon
ABSTLB09 #ACR26 RheumNow (on X)
We've seen PD-1 agonists - rosnilimab's phase 2b
What about other immune checkpoint agonists, though?
LAG-3 we know from ICI therapy (relatlimab)
Prepare to see LAG-3 agonist drug development soon
ABSTLB09 #ACR26 RheumNow (on X)
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
✍️by Saud Almawash
Citations: 57✅
Find out more👉 www.mdpi.com/2072-6694/17...
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
✍️by Saud Almawash
Citations: 57✅
Find out more👉 www.mdpi.com/2072-6694/17...
->Nature | More on "Cancer immunotherapy conditional biologics" at BigEarthData.ai
Join @medliveaboards.bsky.social Nov. 11 at 12:45 pm ET for an expert discussion of an investigational, chemo-free anti-CTLA-4 approach.
Register: www.medlive.com/aaci/show/26...
#NSCLC #LungCancer
Join @medliveaboards.bsky.social Nov. 11 at 12:45 pm ET for an expert discussion of an investigational, chemo-free anti-CTLA-4 approach.
Register: www.medlive.com/aaci/show/26...
#NSCLC #LungCancer
https://www.biorxiv.org/content/10.64898/2026.10.30.763258v1
https://www.biorxiv.org/content/10.64898/2026.10.30.763258v1
CTLA Guide for Plant Appraisal: cost, income and market (sales comparison) approaches.
Free lessons: arboristpass.com/free #Trees #Arborist #TreeCare
CTLA Guide for Plant Appraisal: cost, income and market (sales comparison) approaches.
Free lessons: arboristpass.com/free #Trees #Arborist #TreeCare
Let’s start with CTLA-4 in T cells:
mRNA might be high.
But the surface protein?
It's tightly controlled via intracellular trafficking.
Let’s start with CTLA-4 in T cells:
mRNA might be high.
But the surface protein?
It's tightly controlled via intracellular trafficking.
🧵4/7
🧵4/7
Common CTLA4 genetic variants are associated with susceptibility to multiple autoimmune diseases, but how they affect human Treg biology has remained unclear.
🧵2/7
Common CTLA4 genetic variants are associated with susceptibility to multiple autoimmune diseases, but how they affect human Treg biology has remained unclear.
🧵2/7
By genotyping a large cohort, we identified individuals with rare haplotypes, through the analysis of which we demonstrated that rs3087243 dictates the level of CTLA-4 expression in T cells.
🧵3/7
By genotyping a large cohort, we identified individuals with rare haplotypes, through the analysis of which we demonstrated that rs3087243 dictates the level of CTLA-4 expression in T cells.
🧵3/7
academic.oup.com/jimmunol/art...
academic.oup.com/jimmunol/art...